Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 September 2015
|
| In: |
Journal of clinical oncology
Year: 2015, Volume: 33, Issue: 25, Pages: 2735-2746 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.2015.61.5005 |
| Online Access: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1200/JCO.2015.61.5005
|
| Author Notes: | Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1551106957 | ||
| 003 | DE-627 | ||
| 005 | 20220813105851.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 161219s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2015.61.5005 |2 doi | |
| 035 | |a (DE-627)1551106957 | ||
| 035 | |a (DE-576)481106952 | ||
| 035 | |a (DE-599)BSZ481106952 | ||
| 035 | |a (OCoLC)1340947366 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sandmann, Thomas |e VerfasserIn |0 (DE-588)132398281 |0 (DE-627)521959527 |0 (DE-576)299120813 |4 aut | |
| 245 | 1 | 0 | |a Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide |b retrospective analysis of the AVAglio trial |c Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais |
| 264 | 1 | |c 1 September 2015 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.12.2016 | ||
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 33(2015), 25, Seite 2735-2746 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnas |a Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide retrospective analysis of the AVAglio trial |
| 773 | 1 | 8 | |g volume:33 |g year:2015 |g number:25 |g pages:2735-2746 |g extent:12 |a Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide retrospective analysis of the AVAglio trial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2015.61.5005 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20161219 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 7 | ||
| 999 | |a KXP-PPN1551106957 |e 2949244882 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1200/JCO.2015.61.5005"],"eki":["1551106957"]},"origin":[{"dateIssuedDisp":"1 September 2015","dateIssuedKey":"2015"}],"name":{"displayForm":["Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Cloughesy, Olivier L. Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, Nicola Moore, Samir Kharbanda, Franklin Peale, Priti Hegde, Lauren E. Abrey, Heidi S. Phillips, and Carlos Bais"]},"recId":"1551106957","person":[{"given":"Thomas","role":"aut","family":"Sandmann","display":"Sandmann, Thomas"},{"family":"Wick","given":"Wolfgang","role":"aut","display":"Wick, Wolfgang"}],"title":[{"title":"Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide","subtitle":"retrospective analysis of the AVAglio trial","title_sort":"Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide"}],"language":["eng"],"physDesc":[{"extent":"12 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"pubHistory":["1.1983 -"],"part":{"year":"2015","issue":"25","volume":"33","pages":"2735-2746","extent":"12","text":"33(2015), 25, Seite 2735-2746"},"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology","subtitle":"JCO : an American Society of Clinical Oncology journal"}],"recId":"313116962","disp":"Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide retrospective analysis of the AVAglio trialJournal of clinical oncology","id":{"issn":["1527-7755"],"zdb":["2005181-5"],"eki":["313116962"]},"origin":[{"dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}]}],"note":["Gesehen am 19.12.2016"]} | ||
| SRT | |a SANDMANNTHPATIENTSWI1201 | ||